Iambic Therapeutics

IAM
13.10011.73% ( -1.740 )
Closed: Nov 13, 16:00:00 (EDT)

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Iambic Therapeutics(IAM) the Revenue is 6.377 M (+224.7%);the EBIT is -26.76 M (-50%);the EPS is -1.12 (-45.13%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.01B224.67%
----
----
EBIT
-0.03B50.00%
----
----
EPS
-1.117945.13%
----
----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateDec 23, 2026
Estimate Revenue8.292 M
Estimate EBIT-31.05 M
Estimate EPS-0.765

Revenue

ActualEstimateUnit: USD
Quarterly

EBIT

ActualEstimateUnit: USD
Quarterly

Net income

ActualEstimateUnit: USD
Quarterly

EPS

ActualEstimateUnit: USD
Quarterly